Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
Clinical trial NCT01641042 · COMPLETED
Trial details
- NCT number
- NCT01641042
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-10
- Primary completion
- 2014-10-10
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.